Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Diagnostic Medical Systems

BATS-CHIXE:DGMP
Snowflake Description

Imperfect balance sheet and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
DGMP
BATS-CHIXE
€15M
Market Cap
  1. Home
  2. GB
  3. Healthcare
Company description

Diagnostic Medical Systems S.A. operates in the medical imaging industry in France. The last earnings update was 190 days ago. More info.


Add to Portfolio Compare Print
  • Diagnostic Medical Systems has significant price volatility in the past 3 months.
DGMP Share Price and Events
7 Day Returns
0%
BATS-CHIXE:DGMP
-1.2%
GB Medical Equipment
0.1%
GB Market
1 Year Returns
12.8%
BATS-CHIXE:DGMP
-0.3%
GB Medical Equipment
-23.6%
GB Market
DGMP Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Diagnostic Medical Systems (DGMP) 0% -6.3% - 12.8% - -48%
GB Medical Equipment -1.2% -12% -19.1% -0.3% -2.3% 20.9%
GB Market 0.1% -15.5% -27% -23.6% -24.3% -23.5%
1 Year Return vs Industry and Market
  • DGMP outperformed the Medical Equipment industry which returned -0.3% over the past year.
  • DGMP outperformed the Market in United Kingdom of Great Britain and Northern Ireland which returned -23.6% over the past year.
Price Volatility
DGMP
Industry
5yr Volatility vs Market
Related Companies

DGMP Value

 Is Diagnostic Medical Systems undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Diagnostic Medical Systems. This is due to cash flow or dividend data being unavailable. The share price is €1.04.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Diagnostic Medical Systems's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Diagnostic Medical Systems's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BATS-CHIXE:DGMP PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in EUR €-0.33
ENXTPA:DGM Share Price ** ENXTPA (2020-03-16) in EUR €0.92
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry PE Ratio Median Figure of 11 Publicly-Listed Medical Equipment Companies 25.55x
United Kingdom of Great Britain and Northern Ireland Market PE Ratio Median Figure of 748 Publicly-Listed Companies 12.61x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Diagnostic Medical Systems.

BATS-CHIXE:DGMP PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ENXTPA:DGM Share Price ÷ EPS (both in EUR)

= 0.92 ÷ -0.33

-2.81x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Diagnostic Medical Systems is loss making, we can't compare its value to the GB Medical Equipment industry average.
  • Diagnostic Medical Systems is loss making, we can't compare the value of its earnings to the United Kingdom of Great Britain and Northern Ireland market.
Price based on expected Growth
Does Diagnostic Medical Systems's expected growth come at a high price?
Raw Data
BATS-CHIXE:DGMP PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -2.81x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry PEG Ratio Median Figure of 8 Publicly-Listed Medical Equipment Companies 2x
United Kingdom of Great Britain and Northern Ireland Market PEG Ratio Median Figure of 517 Publicly-Listed Companies 0.99x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Diagnostic Medical Systems, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Diagnostic Medical Systems's assets?
Raw Data
BATS-CHIXE:DGMP PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in EUR €1.00
ENXTPA:DGM Share Price * ENXTPA (2020-03-16) in EUR €0.92
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry PB Ratio Median Figure of 20 Publicly-Listed Medical Equipment Companies 2.83x
United Kingdom of Great Britain and Northern Ireland Market PB Ratio Median Figure of 1,323 Publicly-Listed Companies 1.11x
BATS-CHIXE:DGMP PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ENXTPA:DGM Share Price ÷ Book Value per Share (both in EUR)

= 0.92 ÷ 1.00

0.93x

* Primary Listing of Diagnostic Medical Systems.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Diagnostic Medical Systems is good value based on assets compared to the GB Medical Equipment industry average.
X
Value checks
We assess Diagnostic Medical Systems's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Diagnostic Medical Systems has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

DGMP Future Performance

 How is Diagnostic Medical Systems expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Diagnostic Medical Systems has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
21.1%
Expected Medical Equipment industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Diagnostic Medical Systems expected to grow at an attractive rate?
  • Unable to compare Diagnostic Medical Systems's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Diagnostic Medical Systems's earnings growth to the United Kingdom of Great Britain and Northern Ireland market average as no estimate data is available.
  • Unable to compare Diagnostic Medical Systems's revenue growth to the United Kingdom of Great Britain and Northern Ireland market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
BATS-CHIXE:DGMP Future Growth Rates Data Sources
Data Point Source Value (per year)
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 21.1%
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 6.2%
United Kingdom of Great Britain and Northern Ireland Market Earnings Growth Rate Market Cap Weighted Average 15.5%
United Kingdom of Great Britain and Northern Ireland Market Revenue Growth Rate Market Cap Weighted Average 2.5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BATS-CHIXE:DGMP Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (9 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BATS-CHIXE:DGMP Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2019-06-30 31 1 -5
2019-03-31 29 0 -5
2018-12-31 28 -1 -5
2018-09-30 28 -2 -5
2018-06-30 29 -3 -5
2018-03-31 30 -3 -4
2017-12-31 30 -4 -3
2017-09-30 34 -3 -2
2017-06-30 37 -2 0
2017-03-31 39 -1 -1
2016-12-31 41 -1 -1
2016-09-30 42 -2 -1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Diagnostic Medical Systems is high growth as no earnings estimate data is available.
  • Unable to determine if Diagnostic Medical Systems is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BATS-CHIXE:DGMP Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (9 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Diagnostic Medical Systems Company Filings, last reported 9 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:DGMP Past Financials Data
Date (Data in EUR Millions) EPS *
2019-06-30 -0.33
2019-03-31 -0.33
2018-12-31 -0.33
2018-09-30 -0.33
2018-06-30 -0.33
2018-03-31 -0.26
2017-12-31 -0.19
2017-09-30 -0.10
2017-06-30 0.00
2017-03-31 -0.03
2016-12-31 -0.07
2016-09-30 -0.07

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Diagnostic Medical Systems will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of DGMP’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. Diagnostic Medical Systems's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Diagnostic Medical Systems's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Diagnostic Medical Systems has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

DGMP Past Performance

  How has Diagnostic Medical Systems performed over the past 5 years?

  • Diagnostic Medical Systems's last earnings update was 190 days ago.
The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Diagnostic Medical Systems's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Diagnostic Medical Systems does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Diagnostic Medical Systems's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Diagnostic Medical Systems's 1-year growth to the GB Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
Diagnostic Medical Systems's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Diagnostic Medical Systems Company Filings, last reported 9 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:DGMP Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 30.52 -5.29 12.87
2019-03-31 29.06 -5.35 12.83
2018-12-31 27.60 -5.40 12.79
2018-09-30 28.15 -5.39 12.86
2018-06-30 28.70 -5.38 12.93
2018-03-31 29.56 -4.22 12.97
2017-12-31 30.41 -3.05 13.01
2017-09-30 33.53 -1.54 14.67
2017-06-30 36.64 -0.03 16.32
2017-03-31 38.96 -0.52 17.50
2016-12-31 41.27 -1.02 18.69
2016-09-30 41.64 -1.08 18.22
2016-06-30 42.01 -1.14 17.75
2016-03-31 40.27 -1.30 17.01
2015-12-31 38.53 -1.47 16.27
2015-09-30 35.20 -1.22 14.67
2015-06-30 31.88 -0.98 13.08
2015-03-31 28.90 -1.04 11.59
2014-12-31 25.93 -1.11 10.10
2014-09-30 24.74 -1.03 9.38
2014-06-30 23.55 -0.96 8.66
2014-03-31 23.40 -0.97 8.63
2013-12-31 23.26 -0.97 8.59
2013-09-30 24.42 -0.90 8.54
2013-06-30 25.57 -0.82 8.50

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Diagnostic Medical Systems has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Diagnostic Medical Systems has efficiently used its assets last year compared to the GB Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Diagnostic Medical Systems improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Diagnostic Medical Systems's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Diagnostic Medical Systems has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

DGMP Health

 How is Diagnostic Medical Systems's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Diagnostic Medical Systems's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Diagnostic Medical Systems is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Diagnostic Medical Systems's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Diagnostic Medical Systems's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 3.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Diagnostic Medical Systems Company Filings, last reported 9 months ago.

BATS-CHIXE:DGMP Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 16.11 6.91 0.70
2019-03-31 16.11 6.91 0.70
2018-12-31 17.88 6.62 1.05
2018-09-30 17.88 6.62 1.05
2018-06-30 21.50 6.42 2.30
2018-03-31 21.50 6.42 2.30
2017-12-31 23.35 5.76 4.12
2017-09-30 23.35 5.76 4.12
2017-06-30 25.19 6.13 8.42
2017-03-31 25.19 6.13 8.42
2016-12-31 28.27 6.20 8.14
2016-09-30 28.27 6.20 8.14
2016-06-30 25.95 6.15 6.24
2016-03-31 25.95 6.15 6.24
2015-12-31 25.27 6.22 7.35
2015-09-30 25.27 6.22 7.35
2015-06-30 23.20 4.72 9.20
2015-03-31 23.20 4.72 9.20
2014-12-31 22.01 4.81 10.18
2014-09-30 22.01 4.81 10.18
2014-06-30 12.73 2.71 2.84
2014-03-31 12.73 2.71 2.84
2013-12-31 13.47 3.18 5.22
2013-09-30 13.47 3.18 5.22
2013-06-30 13.26 2.29 3.51
  • Diagnostic Medical Systems's level of debt (42.9%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (21.3% vs 42.9% today).
  • Debt is not well covered by operating cash flow (10.3%, less than 20% of total debt).
  • Unable to confirm if the interest payments on Diagnostic Medical Systems's debt are well covered by earnings due to lack of past financial data.
X
Financial health checks
We assess Diagnostic Medical Systems's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Diagnostic Medical Systems has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

DGMP Dividends

 What is Diagnostic Medical Systems's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Diagnostic Medical Systems dividends.
If you bought €2,000 of Diagnostic Medical Systems shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Diagnostic Medical Systems's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Diagnostic Medical Systems's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BATS-CHIXE:DGMP Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 2.2%
United Kingdom of Great Britain and Northern Ireland Market Average Dividend Yield Market Cap Weighted Average of 588 Stocks 5.6%
United Kingdom of Great Britain and Northern Ireland Minimum Threshold Dividend Yield 10th Percentile 1.3%
United Kingdom of Great Britain and Northern Ireland Bottom 25% Dividend Yield 25th Percentile 2.6%
United Kingdom of Great Britain and Northern Ireland Top 25% Dividend Yield 75th Percentile 7.1%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Diagnostic Medical Systems has not reported any payouts.
  • Unable to verify if Diagnostic Medical Systems's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Diagnostic Medical Systems's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Diagnostic Medical Systems has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Diagnostic Medical Systems's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Diagnostic Medical Systems afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Diagnostic Medical Systems has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

DGMP Management

 What is the CEO of Diagnostic Medical Systems's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jean-Paul Ansel
COMPENSATION €257,000
CEO Bio

Mr. Jean-Paul Ansel serves as the Chief Executive Officer of Diagnostic Medical Systems S.A. and has been its Chairman since 2010. Mr. Ansel served as the Chairman and Chief Executive Officer of Alpha MOS S.A. since November 30, 2015.

CEO Compensation
  • Jean-Paul's compensation has increased whilst company is loss making.
  • Jean-Paul's remuneration is lower than average for companies of similar size in United Kingdom of Great Britain and Northern Ireland.
Management Team

Jean-Paul Ansel

TITLE
Chairman of the Board & CEO
COMPENSATION
€257K

Nathalie Richard

TITLE
Human Resources Director
TENURE
1.2 yrs

Samuel Sancerni

TITLE
Deputy Chief Executive Officer and Director
COMPENSATION
€141K
Board of Directors

Jean-Paul Ansel

TITLE
Chairman of the Board & CEO
COMPENSATION
€257K
TENURE
10.3 yrs

Samuel Sancerni

TITLE
Deputy Chief Executive Officer and Director
COMPENSATION
€141K

Simonyi See-Nuan

TITLE
Director
COMPENSATION
€12K
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Diagnostic Medical Systems's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Diagnostic Medical Systems has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

DGMP News

Simply Wall St News

DGMP Company Info

Description

Diagnostic Medical Systems S.A. operates in the medical imaging industry in France. It offers radiography/fluoroscopy, retrofit kits, mammography, chest and bone rooms, mobiles, bone densitometry, 3D reconstruction, mobile C-arms, and posturology solutions. The company also exports its products. Diagnostic Medical Systems S.A. was founded in 1993 and is based in Mauguio, France.

Details
Name: Diagnostic Medical Systems S.A.
DGMP
Exchange: BATS-CHIXE
Founded: 1993
€14,863,152
16,120,556
Website: http://www.dms.com
Address: Diagnostic Medical Systems S.A.
393 rue Charles Lindbergh,
Mauguio,
Languedoc-Roussillon, 34130,
France
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ENXTPA DGM Ordinary Shares Euronext Paris FR EUR 20. May 1998
LSE 0RIA Ordinary Shares London Stock Exchange GB EUR 20. May 1998
BATS-CHIXE DGMP Ordinary Shares BATS 'Chi-X Europe' GB EUR 20. May 1998
Number of employees
Current staff
Staff numbers
145
Diagnostic Medical Systems employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/07 22:56
End of day share price update: 2020/03/16 00:00
Last earnings filing: 2019/09/30
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.